{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:23:38Z","timestamp":1777580618330,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ume\u00e5 University Medical Faculty Foundations"},{"name":"Strategic Neuroscience Program Ume\u00e5 University-Karolinska Institute"},{"DOI":"10.13039\/501100008084","name":"Neurof\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SciLifeLab and Cancer Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.mcn.2019.06.003","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T02:50:46Z","timestamp":1560307846000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["1H NMR profiling of the 6-OHDA parkinsonian rat brain reveals metabolic alterations and signs of recovery after N-acetylcysteine treatment"],"prefix":"10.1016","volume":"98","author":[{"given":"Ana","family":"Virel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilona","family":"Dudka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rutger","family":"Laterveer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"af Bjerk\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2019.06.003_bb0005","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/nprot.2010.45","article-title":"High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues","volume":"5","author":"Beckonert","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mcn.2019.06.003_bb0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.tips.2013.01.001","article-title":"The promise of N-acetylcysteine in neuropsychiatry","volume":"34","author":"Berk","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mcn.2019.06.003_bb0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0893-133X(99)00096-2","article-title":"The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia","volume":"22","author":"Bertolino","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mcn.2019.06.003_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson's disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.mcn.2019.06.003_bb0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.expneurol.2017.10.002","article-title":"Compensatory mechanisms in Parkinson's disease: circuits adaptations and role in disease modification","volume":"298","author":"Blesa","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.mcn.2019.06.003_bb0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MCC.0000000000000072","article-title":"Lactate and the injured brain: friend or foe?","volume":"20","author":"Bouzat","year":"2014","journal-title":"Curr. Opin. Crit. Care"},{"key":"10.1016\/j.mcn.2019.06.003_bb0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41419-018-0468-2","article-title":"Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization","volume":"9","author":"Che","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mcn.2019.06.003_bb0040","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s12035-013-8598-0","article-title":"Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model","volume":"49","author":"Chotibut","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mcn.2019.06.003_bb0045","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.mehy.2006.02.047","article-title":"N-Acetylaspartate as a reservoir for glutamate","volume":"67","author":"Clark","year":"2006","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mcn.2019.06.003_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012333","article-title":"Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice","volume":"5","author":"Clark","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2019.06.003_bb0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/nbm.2817","article-title":"An in vivo ultrahigh field 14.1 T (1) H-MRS study on 6-OHDA and alpha-synuclein-based rat models of Parkinson's disease: GABA as an early disease marker","volume":"26","author":"Coune","year":"2013","journal-title":"NMR Biomed."},{"key":"10.1016\/j.mcn.2019.06.003_bb0060","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1101\/gr.116764.110","article-title":"A metabolomic and systems biology perspective on the brain of the Fragile X syndrome mouse model","volume":"21","author":"Davidovic","year":"2011","journal-title":"Genome Res."},{"key":"10.1016\/j.mcn.2019.06.003_bb0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","article-title":"N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action","volume":"36","author":"Dean","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.mcn.2019.06.003_bb0070","first-page":"461","article-title":"The role of oxidative stress in Parkinson's disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.mcn.2019.06.003_bb0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tox.2009.10.026","article-title":"Changes in mouse brain metabolism following a convulsive dose of soman: a proton HRMAS NMR study","volume":"267","author":"Fauvelle","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.mcn.2019.06.003_bb0080","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1021\/pr300291d","article-title":"Prediction of neuroprotective treatment efficiency using a HRMAS NMR-based statistical model of refractory status epilepticus on mouse: a metabolomic approach supported by histology","volume":"11","author":"Fauvelle","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mcn.2019.06.003_bb0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12035-012-8336-z","article-title":"Metabolic changes detected by ex vivo high resolution 1H NMR spectroscopy in the striatum of 6-OHDA-induced Parkinson's rat","volume":"47","author":"Gao","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mcn.2019.06.003_bb0090","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/nbm.1203","article-title":"Reduced brain glutamate in patients with Parkinson's disease","volume":"21","author":"Griffith","year":"2008","journal-title":"NMR Biomed."},{"key":"10.1016\/j.mcn.2019.06.003_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2015.00202","article-title":"Probing astrocyte metabolism in vivo: proton magnetic resonance spectroscopy in the injured and aging brain","volume":"7","author":"Harris","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.mcn.2019.06.003_bb0100","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.freeradbiomed.2008.12.018","article-title":"Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2","volume":"46","author":"Harrison","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mcn.2019.06.003_bb0105","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.tips.2008.03.007","article-title":"Parkinson's disease and pesticides: a toxicological perspective","volume":"29","author":"Hatcher","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mcn.2019.06.003_bb0110","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/acschemneuro.7b00034","article-title":"Are dopamine oxidation metabolites involved in the loss of dopaminergic neurons in the nigrostriatal system in Parkinson's disease?","volume":"8","author":"Herrera","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.mcn.2019.06.003_bb0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e31829ae713","article-title":"N-acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases","volume":"36","author":"Holmay","year":"2013","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.mcn.2019.06.003_bb0120","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.chembiol.2014.09.016","article-title":"Brain region mapping using global metabolomics","volume":"21","author":"Ivanisevic","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.mcn.2019.06.003_bb0125","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.ajpath.2015.02.016","article-title":"The mouse brain metabolome region-specific signatures and response to Excito toxic neuronal injury","volume":"185","author":"Jaeger","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mcn.2019.06.003_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JAD-130023","article-title":"H-1 NMR metabolomic signatures in five brain regions of the A beta PPswe Tg2576 mouse model of Alzheimer's disease at four ages","volume":"39","author":"Lalande","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2019.06.003_bb0135","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/jcbfm.2009.8","article-title":"Evolution of the neurochemical profile after transient focal cerebral ischemia in the mouse brain","volume":"29","author":"Lei","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.mcn.2019.06.003_bb0140","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/jnr.21926","article-title":"Protective function of taurine in glutamate-induced apoptosis in cultured neurons","volume":"87","author":"Leon","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mcn.2019.06.003_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2011.09.013","article-title":"The interhemispheric connections of the striatum: implications for Parkinson's disease and drug-induced dyskinesias","volume":"87","author":"Lieu","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.mcn.2019.06.003_bb0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/cells8020097","article-title":"Low molecular mass myocardial hyaluronan in human hypertrophic cardiomyopathy","volume":"8","author":"Lor\u00e9n","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.mcn.2019.06.003_bb0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mehy.2012.03.021","article-title":"N-acetyl-cysteine in the treatment of Parkinson's disease. What are we waiting for?","volume":"79","author":"Mart\u00ednez-Banaclocha","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mcn.2019.06.003_bb0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.nbd.2016.01.019","article-title":"Loss of DJ-1 impairs antioxidant response by altered glutamine and serine metabolism","volume":"89","author":"Meiser","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2019.06.003_bb0165","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/SLA.0b013e31829d5c45","article-title":"Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies","volume":"259","author":"Mirnezami","year":"2014","journal-title":"Ann. Surg."},{"key":"10.1016\/j.mcn.2019.06.003_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pneurobio.2006.12.003","article-title":"N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology","volume":"81","author":"Moffett","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.mcn.2019.06.003_bb0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.taap.2016.02.010","article-title":"Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo","volume":"296","author":"Nouraei","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.mcn.2019.06.003_bb0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuroscience.2017.08.023","article-title":"An altered blood\u2013brain barrier contributes to brain iron accumulation and neuroinflammation in the 6-OHDA rat model of Parkinson's disease","volume":"362","author":"Olmedo-D\u00edaz","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.mcn.2019.06.003_bb0185","first-page":"21","article-title":"Antioxidant-enriched diet affects early microglia accumulation and promotes regeneration of the striatal dopamine system after a 6-hydroxidopamine-induced lesion in a rat","volume":"6","author":"Rehnmark","year":"2012","journal-title":"J. Neurol. Exp. Neurosci."},{"key":"10.1016\/j.mcn.2019.06.003_bb0190","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/cne.1098","article-title":"Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways","volume":"432","author":"Roedter","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.mcn.2019.06.003_bb0195","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/jnr.10043","article-title":"Lactate reduces glutamate-induced neurotoxicity in rat cortex","volume":"66","author":"Ros","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mcn.2019.06.003_bb0200","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0306-4522(00)00501-7","article-title":"Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease","volume":"102","author":"Ross","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.mcn.2019.06.003_bb0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0304-3940(96)12821-4","article-title":"Intrastriatal taurine increases striatal extracellular dopamine in a tetrodotoxin-sensitive manner in rats","volume":"212","author":"Ruotsalainen","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mcn.2019.06.003_bb0210","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.mcn.2019.06.003_bb0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4062\/biomolther.2017.251","article-title":"Effects and mechanisms of taurine as a therapeutic agent","volume":"26","author":"Schaffer","year":"2018","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.mcn.2019.06.003_bb0220","doi-asserted-by":"crossref","DOI":"10.4137\/BMI.S6794","article-title":"H HRMAS NMR derived bio-markers related to tumor grade, tumor cell fraction, and cell proliferation in prostate tissue samples","volume":"6","author":"Stenman","year":"2011","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.mcn.2019.06.003_bb0225","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.expneurol.2005.08.013","article-title":"Blueberry- and spirulina-enriched diets enhance striatal dopamine regeneration and induce a rapid, transient microglia activation after injury of the nigrostriatal dopamine system","volume":"196","author":"Str\u00f6mberg","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.mcn.2019.06.003_bb0230","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1179\/1476830511Y.0000000033","article-title":"Cellular and molecular mechanisms of antioxidants in Parkinson's disease","volume":"15","author":"Sutachan","year":"2012","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.mcn.2019.06.003_bb0235","first-page":"1","article-title":"Retrograde axonal degeneration in Parkinson's disease","volume":"6","author":"Tagliaferro","year":"2016","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.mcn.2019.06.003_bb0240","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brainres.2006.08.082","article-title":"Protection of nigral cell death by bilateral subthalamic nucleus stimulation","volume":"1120","author":"Temel","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.mcn.2019.06.003_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112941","article-title":"Magnetic resonance imaging (MRI) to study striatal iron accumulation in a rat model of Parkinson's disease","volume":"9","author":"Virel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2019.06.003_bb0250","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1111\/ejn.13044","article-title":"Magnetic resonance imaging as a tool to image neuroinflammation in a rat model of Parkinson's disease - phagocyte influx to the brain is promoted by bilberry-enriched diet","volume":"42","author":"Virel","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.mcn.2019.06.003_bb0255","article-title":"Metabolomics approach reveals integrated metabolic network associated with serotonin deficiency","volume":"5","author":"Weng","year":"2015","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.mcn.2019.06.003_bb0260","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.biopha.2008.01.017","article-title":"Glutathione and Parkinson's disease: is this the elephant in the room?","volume":"62","author":"Zeevalk","year":"2008","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mcn.2019.06.003_bb0265","first-page":"630","article-title":"Reduced plasma taurine level in Parkinson's disease: association with motor severity and levodopa treatment","volume":"126","author":"Zhang","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.mcn.2019.06.003_bb0270","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1007\/s12035-015-9579-2","article-title":"NMR-based metabolomics reveal a recovery from metabolic changes in the striatum of 6-OHDA-induced rats treated with basic fibroblast growth factor","volume":"53","author":"Zheng","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mcn.2019.06.003_bb0275","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11011-016-9949-0","article-title":"NMR-based metabolomics reveals brain region-specific metabolic alterations in streptozotocin-induced diabetic rats with cognitive dysfunction","volume":"32","author":"Zheng","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.mcn.2019.06.003_bb0280","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbadis.2016.11.003","article-title":"Cognitive decline in type 2 diabetic db\/db mice may be associated with brain region-specific metabolic disorders","volume":"1863","author":"Zheng","year":"2017","journal-title":"Bba-Mol Basis Dis"},{"key":"10.1016\/j.mcn.2019.06.003_bb0285","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","article-title":"Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease","volume":"155","author":"Zucca","year":"2017","journal-title":"Prog. Neurobiol."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743119300491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743119300491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T07:44:55Z","timestamp":1569224695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743119300491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":57,"alternative-id":["S1044743119300491"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2019.06.003","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1H NMR profiling of the 6-OHDA parkinsonian rat brain reveals metabolic alterations and signs of recovery after N-acetylcysteine treatment","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2019.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}